| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.3 | $0-$5k | 0.00 |
Summary
A vulnerability identified as critical has been detected in Aterm 0.42. Affected by this issue is some unknown functionality of the component Escape Character Handler. This manipulation causes privileges management. This vulnerability is tracked as CVE-2003-0067. No exploit exists.
Details
A vulnerability classified as critical was found in Aterm 0.42. Affected by this vulnerability is some unknown functionality of the component Escape Character Handler. The manipulation with an unknown input leads to a privileges management vulnerability. The CWE definition for the vulnerability is CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:
The aterm terminal emulator 0.42 allows attackers to modify the window title via a certain character escape sequence and then insert it back to the command line in the user s terminal, e.g. when the user views a file containing the malicious sequence, which could allow the attacker to execute arbitrary commands.
The weakness was disclosed 03/18/2003 by H D Moore (DiGiT) with Digital Defense (Website). The advisory is shared at archives.neohapsis.com. This vulnerability is known as CVE-2003-0067. The exploitation appears to be easy. The attack can be launched remotely. The exploitation doesn't need any form of authentication. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1068 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at X-Force (11414) and SecurityFocus (BID 6940†). The entries VDB-20155, VDB-20156, VDB-20157 and VDB-20158 are pretty similar. If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.3VulDB Meta Temp Score: 7.3
VulDB Base Score: 7.3
VulDB Temp Score: 7.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
02/24/2003 🔍03/18/2003 🔍
03/18/2003 🔍
08/08/2014 🔍
06/13/2018 🔍
Sources
Advisory: archives.neohapsis.comResearcher: H D Moore (DiGiT)
Organization: Digital Defense
Status: Not defined
CVE: CVE-2003-0067 (🔍)
GCVE (CVE): GCVE-0-2003-0067
GCVE (VulDB): GCVE-100-20197
X-Force: 11414 - Multiple vendor terminal emulator window title command execution
SecurityFocus: 6940 - XTerm Window Title Reporting Escape Sequence Command Execution Vulnerability
See also: 🔍
Entry
Created: 08/08/2014 11:31Updated: 06/13/2018 09:19
Changes: 08/08/2014 11:31 (44), 06/13/2018 09:19 (11)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.